<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03866642</url>
  </required_header>
  <id_info>
    <org_study_id>Cadence-2019</org_study_id>
    <nct_id>NCT03866642</nct_id>
  </id_info>
  <brief_title>Two Year Follow up of Cadence Total Ankle Replacement</brief_title>
  <official_title>Two Year Follow up of Cadence Total Ankle Replacement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Michael's Hospital, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Michael's Hospital, Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Over the last decades, total ankle replacement (TAR) emerged as a reliable treatment option
      in end-stage ankle osteoarthritis (OA) while preserving motion and physiological load. The
      Cadence™ is a fourth-generation, two-component, fixed-bearing implant with minimal tibial and
      talar resection. It has been in clinical use since July 2016, the purpose of this study was
      to compare the clinical outcome and radiological outcomes of total ankle arthroplasty with
      use of the Cadence™ prosthesis at St. Michael's Hospital.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Over the last decades, total ankle replacement (TAR) emerged as a reliable treatment option
      in end-stage ankle osteoarthritis (OA) while preserving motion and physiological load. The
      Cadence™ is a fourth-generation, two-component, fixed-bearing implant with minimal tibial and
      talar resection. It has been in clinical use since July 2016, the purpose of this study was
      to compare the clinical outcome and radiological outcomes of total ankle arthroplasty with
      use of the Cadence™ prosthesis at St. Michael's Hospital.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">September 1, 2018</start_date>
  <completion_date type="Anticipated">July 2019</completion_date>
  <primary_completion_date type="Actual">January 5, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Implant Survivorship</measure>
    <time_frame>Two Years</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Ankle Arthritis</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cadence Total Ankle Replacment</intervention_name>
    <description>Cadence Total Ankle prosthesis</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with end-stage ankle arthritis requiring surgical intervention.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ankle arthritis treated with Cadence Total Ankle Replacement system

        Exclusion Criteria:

          -  Under 18 years of age
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>St. Michael's Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5B 1W8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 5, 2019</study_first_submitted>
  <study_first_submitted_qc>March 5, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 7, 2019</study_first_posted>
  <last_update_submitted>March 5, 2019</last_update_submitted>
  <last_update_submitted_qc>March 5, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 7, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

